Prostanoid Receptors

14 Item(s)

per page

Set Descending Direction
  1. Laropiprant (MK0524)

    Catalog No. A11483
    Quick View
    DP1 inhibitor
    Laropiprant is used in combination with niacin to reduce blood cholesterol. Laropiprant acts as a DP1 antagonist, reducing the vasodilation. Learn More
  2. Grapiprant (CJ-023423)

    Catalog No. A15964
    Quick View
    prostaglandin EP4 receptor antagonist
    Grapiprant is a novel, potent and selective prostaglandin EP4 receptor antagonist with antihyperalgesic properties. Learn More
  3. TG6-10-1

    Catalog No. A15968
    Quick View
    Prostaglandin E2 receptor antagonist
    TG6-10-1 is a potent and selective antagonist for the prostaglandin E2 receptor subtype EP2. Learn More
  4. CP544326 (Taprenepag)

    Catalog No. A15853
    Quick View
    EP2 Agonist‎
    C-544326 is a potent and selective prostaglandin E2 receptor agonist with EC50 value of 2.8 nM. Learn More
  5. PF-04418948

    Catalog No. A12894
    Quick View
    EP2 Receptor antagonist
    PF-04418948 is a potent and selective prostaglandin EP2 receptor antagonist with IC50 of 16 nM. Phase 1. Learn More
  6. MF498

    Catalog No. A15532
    Quick View
    EP4 receptor antagonist
    MF498 is a novel and selective E prostanoid receptor 4 (EP4 receptor) antagonist, displayed strong binding affinity for the EP4 receptor with Ki of 0.7 nM, Learn More
  7. GW627368

    Catalog No. A15525
    Quick View
    EP4 receptor antagonist
    GW627368 is a novel, potent and selective competitive antagonist of prostanoid EP4 receptor(Ki= 100 nM) with additional human TP receptor affinity(Ki= 150 nM). Learn More
  8. Saikosaponin B2

    Catalog No. A14600
    Quick View
    Prostanoid activator
    Saikosaponin B2 is a saponin activator. Learn More
  9. NS-304 (Selexipag)

    Catalog No. A13880
    Quick View
    prostacyclin receptor agonist
    NS-304 is a selective prostacyclin IP1 receptor agonist (Ki values are 260 and 2100 nM and for human and rat IP receptors, and >10 μM for EP1-4, DP, FP, and TP receptors). Learn More
  10. BAY-u 3405

    Catalog No. A13751
    Quick View
    dual antagonist of TP/DP2
    BAY-u 3405 is an approved human medication for the treatment of allergic rhinitis that has documented activity as an antagonist of the thromboxane receptor (TP receptor). Learn More
  11. Cloprostenol (sodium salt)

    Catalog No. A13498
    Quick View
    Cloprostenol is a synthetic analog of prostaglandin F2α (PGF2α). It is 200 times and 100 times more potent than PGF2α in terminating pregnancy in hamsters and rats, respectively, without the side effects associated with PGF2α. Learn More
  12. MK-2894

    Catalog No. A11497
    Quick View
    EP4 receptor antagonist
    MK-2894 is a highly potent and selective second generation EP4 antagonist. Learn More
  13. Ozagrel hydrochloride

    Catalog No. A11742
    Quick View
    Thromboxane A2 synthesis inhibitor
    Ozagrel is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor. Learn More
  14. KAG-308

    Catalog No. A18389
    Quick View
    EP4 agonist
    KAG-308, a newly-identified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration. Learn More

14 Item(s)

per page

Set Descending Direction